Tuberculosis IgG/IgM Rapid Test Device/Strip (WB/S/P)

The TB IgG/IgM Rapid Test Device/Strip is an antibody-based rapid test used to detect immune response against tuberculosis-related antigens. IgM may suggest a recent immune response, while IgG may indicate previous exposure, later immune response, or ongoing immune activity.

• Tuberculosis, commonly known as TB, is an infectious disease caused by bacteria that most often affects the lungs.
• TB can spread through the air when people with active pulmonary TB cough, sneeze, or spit.
• TB symptoms may include prolonged cough, fever, night sweats, weight loss, chest pain, weakness, and sometimes coughing blood.
• The TB IgG/IgM Rapid Test Device/Strip may support fast screening in professional healthcare settings where additional evaluation is needed.

The TB IgG/IgM Rapid Test Device/Strip by LARKSOIS Pharma may be used in professional diagnostic and tuberculosis screening environments.

Applications

• Hospitals and clinics
• Diagnostic laboratories
• Respiratory care settings
• Public health programs
• TB screening support workflows
• Fever and respiratory clinics
• Medical procurement agencies
• Professional point-of-care screening
• International diagnostic distribution

• The TB IgG/IgM Rapid Test Device/Strip works on lateral flow immunochromatographic assay technology.
• When the specimen is added to the sample area, it migrates across the membrane by capillary action.
• If TB-specific IgG or IgM antibodies are present, they react with coated antigens and create visible test lines.
• The test generally includes IgG line, IgM line, and control line for valid test performance.

The TB IgG/IgM Rapid Test Device/Strip uses rapid lateral flow immunochromatographic technology for qualitative detection of tuberculosis IgG and IgM antibodies in whole blood, serum, or plasma specimens.

Benefits

• Detects TB IgG antibodies
• Detects TB IgM antibodies
• Suitable for whole blood, serum, and plasma
• Available in device or strip format
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Supports professional TB screening workflows

The TB IgG/IgM Rapid Test Device/Strip supports whole blood, serum, and plasma specimens. This flexibility makes the test practical for different laboratory and clinical screening workflows.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the sample area
• Add buffer according to instructions
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The TB IgG/IgM Rapid Test Device/Strip by LARKSOIS Pharma is designed for qualitative detection of TB IgG and IgM antibodies in whole blood, serum, or plasma specimens. Detection of TB antibodies may support screening but should not replace clinical evaluation or confirmatory testing for active TB disease.

• An IgM-positive result may suggest recent immune response to TB-related antigens.
• An IgG-positive result may indicate previous exposure, later immune response, or ongoing immune activity.
• For active TB disease, laboratory confirmation commonly involves sputum testing, microscopy, nucleic acid amplification tests, and culture.
• Results should be interpreted with symptoms, exposure history, chest imaging, sputum testing, and clinical evaluation.

The TB IgG/IgM Rapid Test Device/Strip is intended as a screening aid. It should not replace clinical evaluation, chest imaging, sputum testing, culture, or molecular tests when active TB disease is suspected.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood, serum, or plasma specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• Antibody detection alone cannot confirm active TB disease
• Further clinical and laboratory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects TB IgG antibodies
• Detects TB IgM antibodies
• Suitable for whole blood, serum, and plasma
• Available in device or strip format
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Suitable for international diagnostic supply

Note

The TB IgG/IgM Rapid Test Device/Strip by LARKSOIS Pharma is designed for fast, practical, and accessible tuberculosis antibody screening support.

Steps

• Bring the test device or strip, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the device on a clean flat surface or prepare the strip according to instructions
• Add whole blood, serum, or plasma to the sample area
• Add buffer according to the product insert
• Wait for the recommended reaction time
• Read the IgG, IgM, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

An IgM-positive result may suggest recent immune response to TB-related antigens. An IgG-positive result may indicate previous exposure, later immune response, or ongoing immune activity.

Negative

A negative result means TB IgG/IgM antibodies were not detected at the test’s detectable level. If TB is suspected, further clinical evaluation and laboratory testing may be required.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device or strip.

Instructions

• Store the TB IgG/IgM Rapid Test Device/Strip according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the device or strip
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and patient history

LARKSOIS Pharma provides globally suitable diagnostic products for hospitals, clinics, laboratories, public health programs, healthcare distributors, and procurement agencies. The TB IgG/IgM Rapid Test Device/Strip (WB/S/P) is designed for fast, practical, and accessible TB antibody screening support.

Advantages

• International infectious disease rapid test portfolio
• Reliable TB IgG/IgM antibody screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible tuberculosis screening solution